ANANDA Devices

At Ananda Devices, they collaborate with businesses worldwide, spanning across Canada, the United States, Europe, Brazil, Japan, Korea, Israel, and beyond. Their expertise lies in guiding companies through the design, execution, and analysis of the impacts of medications and chemicals. Ananda Devices leverages their well-established platforms of neuronal networks-on-a-chip and innervated tissues-on-a-chip to deliver innovative solutions to accelerate drug development.

Ananda Devices has partnered with CMTA to validate an in vitro human model for CMT representing a significant step forward in understanding the condition at a cellular level. By working with various partners to explore potential treatments, this initiative holds the promise of identifying more effective therapeutic options for CMT patients. Ultimately, it has the potential to accelerate the development of treatments that could improve the quality of life for those affected by this disease.